It has been found that the compounds of formula (I) provide unexpected advantages in the treatment of cancer, e.g., superior efficacy and/or reduced side effects. The superior efficacy and reduced side effects are seen especially in the treatment of several specific cancer-subindications. In particular, methods of treating pancreatic cancer using compounds of formula (I) in monotherapy or combination therapy are disclosed.
